Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pancreas ; 7(4): 486-96, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1641391

RESUMO

The present studies were done to evaluate the therapeutic potential of several antioxidants and free radical scavengers in three different models of acute pancreatitis. (a) Edematous pancreatitis with acinar cells necrosis was induced by seven hourly intraperitoneal injections of 50 micrograms of caerulein per kg in mice. (b) Hemorrhagic pancreatitis was induced by feeding a choline-deficient, ethionine-supplemented (CDE) diet in mice. (c) Hemorrhagic pancreatitis was induced by retrograde infusion of 0.6 ml of 5% sodium taurocholate into the pancreatic duct in rats. The following antioxidants and free radical scavengers were given at various doses intravenously, subcutaneously, or intraperitoneally before the onset of pancreatitis: Ebselen [2-phenyl-1,2-benzisoselenazol-3(2H)-one], superoxide dismutase, catalase, deferoxamine (Desferal), dimethyl sulfoxide, or allopurinol. The severity of pancreatitis was assessed at various times after its onset by determination of serum amylase and pancreatic weight (edema), by grading of histological alterations, and by determination of survival (survival determined in models of hemorrhagic pancreatitis). In general, free radical scavengers and antioxidants ameliorated edema and inflammation to a greater degree than necrosis and the increase in serum amylase. Superoxide dismutase (as did Ebselen in previous studies) exerted beneficial effects on survival in diet-induced pancreatitis in the absence of marked effects on pancreatic necrosis, suggesting that these beneficial effects are due to amelioration of extrapancreatic complications that often contribute to mortality in acute pancreatitis. None of the antioxidants had major beneficial effects in taurocholate-induced hemorrhagic pancreatitis. Thus, formation of free radicals may be important for progression and outcome in diet-induced and, to a lesser degree, in caerulein-induced pancreatitis but not at all in taurocholate-induced pancreatitis. Different models of pancreatitis may, therefore, involve different degrees and mechanisms of free radical formation. Despite the amelioration of edema and the beneficial effects on mortality seen for some antioxidants in some of the models, antioxidants and free radical scavengers appear to have only a limited potential for treatment of acute pancreatitis.


Assuntos
Antioxidantes/uso terapêutico , Sequestradores de Radicais Livres , Pancreatite/prevenção & controle , Doença Aguda , Administração Oral , Alopurinol/administração & dosagem , Alopurinol/uso terapêutico , Animais , Antioxidantes/administração & dosagem , Catalase/administração & dosagem , Catalase/uso terapêutico , Ceruletídeo , Deficiência de Colina/metabolismo , Desferroxamina/administração & dosagem , Desferroxamina/uso terapêutico , Dieta , Dimetil Sulfóxido/administração & dosagem , Dimetil Sulfóxido/uso terapêutico , Modelos Animais de Doenças , Etionina , Feminino , Injeções Intraperitoneais , Injeções Intravenosas , Injeções Subcutâneas , Masculino , Camundongos , Tamanho do Órgão , Pâncreas/enzimologia , Pâncreas/patologia , Pancreatite/induzido quimicamente , Pancreatite/patologia , Ratos , Ratos Endogâmicos , Índice de Gravidade de Doença , Superóxido Dismutase/administração & dosagem , Superóxido Dismutase/uso terapêutico , Ácido Taurocólico
2.
Pancreas ; 6(3): 282-90, 1991 May.
Artigo em Inglês | MEDLINE | ID: mdl-1713672

RESUMO

This study evaluated the effects of the seleno-organic substance Ebselen [2-phenyl-1,2-benzisoselenazol-3(2H)-one] in two models of acute hemorrhagic and acute edematous pancreatitis. Ebselen is known to catalyze glutathione peroxidase-like reactions and to inhibit lipid peroxidation. Hemorrhagic pancreatitis was induced by feeding a choline-deficient, ethionine-supplemented (CDE) diet to mice for 66 h. Edematous pancreatitis was induced by 7-h subcutaneous injections of 50 micrograms/kg of cerulein in mice. Ebselen was given from the beginning of the CDE diet either as a subcutaneous injection of 100 mg/kg at 6-h intervals or was mixed in with the CDE diet to yield a daily dose of 100 mg/kg of Ebselen. In further experiments, Ebselen was given at various time intervals after the beginning of the CDE diet as subcutaneous injections of 100 mg/kg at 6-h intervals. In the cerulein model, Ebselen was given 5 min prior to each cerulein injection at doses from 10-500 mg/kg. Prophylactic administration of Ebselen given orally or subcutaneously significantly improved survival from 38.5% in the control group of saline-injected CDE-fed mice to 61.9 and 65.0%, respectively. Ebselen also reduced increases in serum amylase and pancreatic weight in the diet model. Therapeutic administration of Ebselen significantly increased survival only when injections were started 20 h after the beginning of the CDE diet (64%), but not when started after 40 h (44%). Similarly, increases in serum amylase and pancreatic weight due to the CDE diet were significantly reduced by Ebselen only when injections were started after 20 h but not when started after 40 h.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Azóis/uso terapêutico , Compostos Organosselênicos , Pancreatite/tratamento farmacológico , Selênio/uso terapêutico , Doença Aguda , Amilases/sangue , Animais , Ceruletídeo , Deficiência de Colina , Dieta , Modelos Animais de Doenças , Etionina/administração & dosagem , Feminino , Radicais Livres , Isoindóis , Masculino , Camundongos , Tamanho do Órgão , Pâncreas/patologia , Pancreatite/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...